Brissot, Pierre
Pietrangelo, Antonello
Adams, Paul C.
de Graaff, Barbara
McLaren, Christine E.
Loréal, Olivier
Article History
First Online: 5 April 2018
Competing interests
: P.B. has received lecture fees from Novartis and consulting fees from Novartis and La Jolla Pharmaceutical Company. A.P. has received lecture fees from Novartis, and consulting fees from Novartis, La Jolla Pharmaceutical Company and Mitsubishi Tanabe Pharma Corporation. O.L. has received a research grant from Novartis. All other authors declare no competing interests.